The Mounjaro injection used for weight loss — what it does and whether it fits your situation

What the decision actually hinges on: health picture first, pen format second

Most people researching this page have already read about the weight-loss results and are now asking a more practical question: is this injection something that genuinely applies to me, or is there a reason it wouldn't work for my situation?

The honest answer is that the injection format is rarely the sticking point. What matters more is whether your BMI, health history and current medicines make tirzepatide clinically appropriate. The licensed eligibility criteria, set out by the MHRA and summarised on the NHS tirzepatide page, cover adults with a BMI of 30 or above, or from 27 upwards if you have at least one weight-related condition such as high blood pressure, high cholesterol, prediabetes, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone, though, doesn't settle it, a prescriber looks at the full clinical picture, including any conditions that make tirzepatide unsuitable.

A history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2 (MEN2), or pancreatitis all require careful discussion. Pregnancy, breastfeeding and actively trying to conceive are reasons the medicine is not recommended. The same applies under the age of 18, where it is not licensed. If you are on an oral contraceptive, UK guidance advises adding a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because tirzepatide can affect how the pill is absorbed. These aren't reasons to rule yourself out before speaking to a prescriber, they are exactly the kind of factors a clinical assessment is there to weigh. Our prescribers are described on the clinical team page if you want to understand who reviews consultations at nume.

How the injection works in practice, from the first pen to maintenance

The Mounjaro KwikPen is a pre-filled, once-weekly subcutaneous injection. Each pen contains four weekly doses, so one pen covers a calendar month. You inject into the fatty tissue just beneath the skin, typically in the abdomen, thigh or upper arm, rotating the site each week. Full guidance on choosing and alternating those sites is covered on the injection site guidance page.

The starting dose is 2.5 mg. That first pen exists primarily to let your body adjust to the medicine, most of the appetite and metabolic effects build through the titration phase. The prescriber typically increases the dose in 2.5 mg steps at roughly four-week intervals, based on how you are tolerating each level, up to a maximum of 15 mg. Step-by-step guidance on using the pen correctly is available on the usage guide.

Storage is straightforward between uses: the pen lives in the fridge at 2–8°C. There is a limited window during which it can be kept at room temperature, but for the exact figure you should read the Patient Information Leaflet that comes with your pen, or check the Mounjaro SmPC on the electronic Medicines Compendium, the number has to match your specific batch and storage conditions, not a figure quoted online.

The most commonly reported side effects are gastrointestinal: nausea, loose stools, constipation and indigestion are all listed. They tend to be most noticeable in the first week or two after starting or after a dose step upward, and settle for most people as the body adapts. Severe, persistent abdominal pain that radiates to the back is different, that warrants urgent medical attention as it can signal pancreatitis, and the MHRA issued a formal Drug Safety Update on this point in January 2026. A sharps container for used needles is a practical necessity; a one-litre sharps bin is available from the nume pharmacy if you need one.

NHS route versus private route, and where the injection fits each

Mounjaro became available on the NHS from 2025, but access is being phased in based on strict criteria. Currently, NHS prescribing applies to people with a BMI of 40 or above and four or more specific weight-related conditions from a defined list. A second cohort (BMI 35–39.9 with four or more conditions) became eligible from June 2026. Even where a patient qualifies on paper, NHS prescribers must participate in the local commissioning arrangement, and patients must engage with structured diet and activity support alongside the injection. The broader context of NHS eligibility and the phased rollout is explained on the main Mounjaro information page.

For people who don't meet NHS criteria, or who don't want to wait, a private prescription is the alternative legal route. The cost of private treatment varies by dose and provider; a price context and what legitimate pricing typically includes is covered on the Mounjaro cost page. Across the weight-loss injection landscape more broadly, the treatment overview sets out what is currently licensed in the UK.

The private route requires the same prescription process (a prescriber assessing clinical suitability) but without the NHS referral pathway or waiting list. At nume, that review happens the same day by a GPhC-registered Independent Prescriber. Once approved, orders placed before midday go out that afternoon (handy if you need a pen before the week turns). Treatment arrives by tracked DPD in plain packaging the next working day.

The practical question the injection format raises most often

Injecting yourself at home is the thing many people feel uncertain about before they start, even if they don't quite say so. It is a reasonable feeling. The pen is designed to make the process simple, the needle is fine, the mechanism is pre-set, and most people report that within the first two or three uses it becomes routine. A separate page covers exactly where to inject, including how to avoid common mistakes with site selection and rotation.

If the injection format itself is a genuine barrier, it is worth knowing that oral GLP-1 options now exist in the UK, though they are a different medicine with a different profile. The assessment of whether the Mounjaro injection is a good fit covers that comparison in more detail. For questions not answered here, the FAQs address some of the practicalities that come up most often.

If you are ready to find out whether you are clinically eligible, a free consultation with a named prescriber is the right next step. Check your eligibility at the weight-loss treatments page.